Market Value1,531,129,746
Total Holdings64
File Date2025-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
EW / Edwards Lifesciences Corporation
ACHV / Achieve Life Sciences, Inc.
LUNG / Pulmonx Corporation
NARI / Inari Medical, Inc.
AVTR / Avantor, Inc.
GMED / Globus Medical, Inc.
INCY / Incyte Corporation
ELVN / Enliven Therapeutics, Inc.
BMY / Bristol-Myers Squibb Company
QQQ / Invesco QQQ Trust, Series 1 Put
QURE / uniQure N.V.
MTSR / Metsera, Inc.
JAZZ / Jazz Pharmaceuticals plc
ERAS / Erasca, Inc.
AXSM / Axsome Therapeutics, Inc. Call
INSM / Insmed Incorporated
SYK / Stryker Corporation
BBIO / BridgeBio Pharma, Inc.
IDYA / IDEAYA Biosciences, Inc.
ACAD / ACADIA Pharmaceuticals Inc. Call
IWM / iShares Trust - iShares Russell 2000 ETF Put
SNDX / Syndax Pharmaceuticals, Inc.
PEN / Penumbra, Inc.
NTRA / Natera, Inc.
YMAB / Y-mAbs Therapeutics, Inc.
ALKS / Alkermes plc
BDX / Becton, Dickinson and Company
TVTX / Travere Therapeutics, Inc.
JANX / Janux Therapeutics, Inc.
ICUI / ICU Medical, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
VIR / Vir Biotechnology, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
KROS / Keros Therapeutics, Inc.
EXAS / Exact Sciences Corporation
DHR / Danaher Corporation
BOLT / Bolt Biotherapeutics, Inc.
IKNA / Ikena Oncology, Inc.
REPL / Replimune Group, Inc.
AVTE / Aerovate Therapeutics, Inc.
MDT / Medtronic plc
ROIV / Roivant Sciences Ltd.
AKRO / Akero Therapeutics, Inc.
ESTA / Establishment Labs Holdings Inc.
PRAX / Praxis Precision Medicines, Inc.
DYN / Dyne Therapeutics, Inc.
BSX / Boston Scientific Corporation
ABBV / AbbVie Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
SRRK / Scholar Rock Holding Corporation
SUPN / Supernus Pharmaceuticals, Inc.
COGT / Cogent Biosciences, Inc.
EWTX / Edgewise Therapeutics, Inc. Put
AXSM / Axsome Therapeutics, Inc.
PTCT / PTC Therapeutics, Inc.
RNA / Atrium Therapeutics, Inc.
RCUS / Arcus Biosciences, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
INBX / Inhibrx Biosciences, Inc.
AVBP / ArriVent BioPharma, Inc.
ANAB / AnaptysBio, Inc.
IMNM / Immunome, Inc.
RAPP / Rapport Therapeutics, Inc.
BIOA / BioAge Labs, Inc.
GILD / Gilead Sciences, Inc.
PHVS / Pharvaris N.V.
VERA / Vera Therapeutics, Inc.
SVRA / Savara Inc.
IMTX / Immatics N.V.
IRON / Disc Medicine, Inc.
SLNO / Soleno Therapeutics, Inc. Put
SLNO / Soleno Therapeutics, Inc.
ISRG / Intuitive Surgical, Inc.
KURA / Kura Oncology, Inc.
BPMC / Blueprint Medicines Corporation
SRPT / Sarepta Therapeutics, Inc.
INZY / Inozyme Pharma, Inc.
DXCM / DexCom, Inc.
EWTX / Edgewise Therapeutics, Inc.
LLY / Eli Lilly and Company
NXTC / NextCure, Inc.